Joseph Monahan, Chief Scientific Officer at Aclaris Therapeutics, Inc. (ACRS), sold 54,330 shares at $15.71 ($854K) on 2022-03-10, disclosed to the SEC on 2022-03-14.
Open-market sale of $854k ACRS by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.71 | 27,165 | $427K | 50.0% |
| 2 | $15.71 | 27,165 | $427K | 50.0% |
| Total | $15.71 avg | 54,330 | $854K | 100% |
| Filing → |
| ACRS | SELL | 2023-06-22 | $123K | — | Filing → |
| ACRS | SELL | 2023-03-03 | $588K | — | Filing → |
| ACRS | SELL | 2023-02-17 | $65K | — | Filing → |